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THE LANCET
Individuals living in houses with a high radon concentration 
have a significantly increased frequency of chromosomal 
aberrations in peripheral lymphocytes, the a-dose being 
delivered mainly by the radon daughter nuclides 2l8Po and 
214Po. Some epidemiological and geographical studies have 
suggested an association between a-particle exposure via 
radon and the occurrence of leukaemia* brain tumours, and 
kidney cancer, especially in children.5
The presence of z,flPo in vehicle exhausts may be unique in 
terms of what is known of its carcinogenic potential at 
environmental exposure levels. In our view it should be 
added to the list of potential carcinogens from motor 
vehicles to which the population is exposed.
* Denis L Henshaw, Paul A Keitch, Patrick R James
H H Wills Physics Laboratory, Bristol BS8 1TL, UK
1 House of Commons Transport Committee. 6th report: transport- 
related air pollution in London, London; HM Stationery Office, Oct 
19, 1994.
2 Sir lohn Houghton (Chairman). Transport and the environment.
Royal Commission on Environmental Pollution, 18th reporta Oct, 
1994.
3 Henshaw DL> Allen JE, Keitch PA, Randle PH. The spatial 
distribution of naturally occurring 21QPo and 226Ra in children’s teeth. 
hit J  Rad Biol 1994; 66i 815-26.
4 Kadhim MA, Lorimore SA, Hepburn MD} Goodhead DT} Buckie VJ, 
Wright EG. a-particle-induced chromosomal instability in human 
bone marrow cells. Lancet 1994; 344: 987-88.
5 Henshaw DL, Eatough JP, Richardson RB. Radon: a causative factor 
in the induction of myeloid leukaemia and other cancers in adults and 
children? Lancet 1990; 335; 1008-12,
WHO’s current policies and plans for reform
Sir—In your Jan 28 editorial you make an ill-informed 
attack on the World Health Organization. By coincidence, 
your editorial appeared as the Executive Board of WHO 
concluded one of its most constructive sessions in recent 
years, during which it endorsed a wide range of important 
reforms and helped to set its targets and priorities for the 
future. No one from The Lancet attended any of the board’s 
eleven working days.
Far from adopting “a fortress mentality, fighting bitterly to 
retain the status quo and meanwhile allowing goodwill and 
opportunities for revitalisation to slip away”, WHO is 
dedicating itself to radical change, to greater openness and 
to closer relations with its partners in health. You seem out 
of touch with WHO's current policies and reforms, and 
make sweeping and inaccurate assertions. For example, you 
say “the mental and societal dimensions of health are 
virtually ignored”—but WHO’s Division of Mental Health 
made world headlines with a major 14-country study of 
mental illness published in December, 1994, in the Journal 
of the American Medical Association, Another example is, 
“Appropriate respect for national sovereignty has been 
overtaken by blind obeisance to narrow national wishes—eg, 
the desire to avoid embarrassment, as in admitting that an 
epidemic is underway”. WHO intervened directly in the 
plague outbreak in India last September. The Director- 
General went to India, met the Prime Minister and Health 
Minister, and set up in India an international team that 
thoroughly investigated the outbreak and produced a full 
report.
You say that WHO “remains essentially unaccountable”, 
but it is directly accountable to each and all of its 189 
member states (whom you also describe as its “official 
shareholders”) through the Executive Board and the World 
Health Assembly. The Board, in its discussions of the WHO 
budget during the past two weeks, has shown that it has no 
doubts of our accountability.
You omit recognition of some undisputed facts: that 
WHO policies and activities result in the savings of millions 
of lives a year, especially those of children in the developing 
world (WHO had a key role in rapidly bringing under 
control the deadly cholera epidemic among Rwandan 
refugees in Zaire last year); that WHO is regarded world­
wide as the leading authority on health; and that the
i
standards it sets and maintains are the yardsticks by which 
countries of the world measure their own health status.
WHO welcomes constructive criticism and responds 
positively to it. Our new communications policy will support 
such a dialogue. But it has become fashionable lately to 
attack WHO, especially in the public health community, 
without much apparent thought to the harm that this does 
not merely to WHO, but also to all those we seek to serve.
Ilona Kickbusch,
Director of Health Promotion, Education and Communication
World Health Organization, CH 1211 Geneva 27, Switzerland
Red wine consumption and oxidation of 
low-density lipoproteins
Sir—There is growing interest in the hypothesis that red 
wine phenolics can protect low-density lipoproteins (LDL) 
against oxidative modification, thereby reducing the risk of 
cardiovascular morbidity. Wine flavonoids inhibit Cu2+- 
mediated oxidation of LDL when added in vitro, 1 but the 
effect of flavonoids eaten with foods is unclear. Although 
Kondo and colleagues (Oct 22, p 1152) report that red wine
(Chateau Lagrange, 1989) consumption for two weeks was
i
associated with an increased resistance of LDL against 
oxidative modification, enthusiasm for their hypothesis 
should be tempered. We have assessed whether the 
consumption of alcohol-poor red wine affects susceptibility 
of LDL to Cu2+^ mediated oxidative modification.
24 healthy non-smoking normolipidaemic volunteers 
consumed white wine for two weeks (baseline period). They 
were then randomly assigned to consumption of 550 mL 
(about 4-5 glasses) daily of white (Loire, 1993) or red wine 
(Italian Chianti Classico, 1991) for 4 weeks (test period), 
with stratification for age, sex, and plasma cholesterol 
concentration. Before distribution, the alcohol content of 
both wines was reduced to 3% by evaporation at 35°C 
without affecting the flavonoid concentrations of the wines. 
Subjects followed a flavonoid-poor diet and abstained from 
tea and red wine. Subjects were not taking vitamin or 
mineral supplements. Fasting blood samples were obtained 
on two days at the end of the baseline period and of the test 
period, to determine the susceptibility of LDL to oxidation 
(variation coefficients <3%). Plasma samples were stored at 
-80°C under nitrogen after the addition of saccharose to 
stabilise the lipoproteins. Lag times and oxidation rates,
Red wine 
(n=13)
White wine 
(n = ll)
M/F ratio 3/10 2/9
Age (yr) 38-2 (9’8) 36-4 (11*8)
Plasma cholesterol (mmol/L) 5-25 (0*71)
i
5-37 (0-82)
Lag time (min)
Baseline period 61-8(7*7) 64-5 (10-4)
Test period 62-7 (11-8) 63-3 (10-8)
Oxidation rate (nmoL dienes/mg LDL protein per min) ■
Baseline period 13-9 (2-1) 14-1 (3-1)
Test period 14-6 (2-3J 13-3 (2-4)
M=male, F=female,
Table: Subjects’ details and in-vltro oxidation characteristics 
of LDL
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indicating the resistance of LDL against oxidative 
modification, were closely similar in both wine groups 
(table).
Thus, in contrast with Kondo and colleagues5 findings* in 
our hands daily consumption of flavonoid-rich red wine did 
not influence the oxidisability of LDL. Variables that might 
account for the differences are the use of different brands of 
red wine, the ethanol content of red wine as an unwanted 
confounding variable, and the analytical precision of the 
assay metiiod used. Our findings do not accord with the 
proposed beneficial effect of red wine consumption on LDL 
oxidation.
*Yolanda B de Rijke, Pierre N M Demacker, Nathalie A Assen, 
Usette M Sloots, Martijn B Katan, Anton F H Stalenhoef
Laboratorium Algemeen Inwendige Geneeskunde, Academisch Ziekenhis Nijmegen, 
Postbus 9101, 6500 HB Nijmegen, Netherlands
1 Frankel E, Kanner J, German J, Parks P, Kinsella JE. Inhibition of 
oxidation of human low-density lipoprotein by phenolic substances in 
red wine. Lancet 1993; 341: 454-57.
Carcinogenicity.of coal-tar shampoo
Sir—van Schooten and colleagues report (Nov 26, p 1505) 
the absorption of polycyclic aromatic hydrocarbons and the 
excretion of 1-hydroxypyrene (1-OH-P) after application of 
a 12-5% coal-tar solution. Coal-tar solution is derived from 
crude coal tar which contains polycyclic aromatic 
hydrocarbons. The level of urinary excretion of the 
polycyclic aromatic hydrocarbons metabolite 1-OH-P has 
been used as a measure of occupational exposure to these 
hydrocarbons and a reflection of the degree of dermal 
absorption of them from coal-tar-containing products.
van Schooten and co-workers examined the urinary 
excretion of 1-OH-P in 11 volunteers in the Netherlands for 
two days after a single hairwash consisting of two 
applications for 20 s each with a coal-tar shampoo. A peak 
urinary 1-OH-P of about 13 nmol was shown at about 24 h 
after application during the two-day period of this study. 
According to their findings* this level of urinary 1-OH-P is 
equivalent to that recorded in occupationally exposed coke- 
oven workers. Details of coal tar exposure* medical 
condition* occupation* and smoking status of the subjects 
tested were not noted. The results were for a limited number, 
of subjects and a small control group.
The potential carcinogenic properties of therapeutic coal­
tar-containing products and the risks associated with their 
use have previously been evaluated. The relevance of van 
Schooten’s results should be assessed in relation to data for 
the potential carcinogenicity of coal-tar shampoos. In the 
USA coal tar is monographed by the Food and Drug 
Administration (FDA) as category I GRAS/E (generally 
regarded as safe and effective) for over-the-counter use in 
die treatment of dandruff, seborrhoea* and psoriasis.1 A risk 
analysis of the potential carcinogenicity of a coal-tar- 
containing solution shampoo would be based on several 
clinical variables that are specific to this mode of exposure 
and which differ from those of occupationally-exposed 
workers. These factors include the amount of shampoo used* 
the duration and extent of application* the number of 
applications per use* the frequency of application* the 
residual amount left on the scalp* and the coal tar absorption 
rate and amount.
Hansen and co-workers1 results2 suggest that raised 
urinary 1-OH-P concentrations might not persist after 
continuous exposure to polycyclic aromatic hydrocarbons. 
In two patients treated once a day with coal-tar pitch 
covering more than 50% of die skin* the concentration of
urinary 1-OH-P was increased about 100-fold, However* 
after tiiree weeks of continuous daily coal-tar treatments* 
urinary excretion of 1-OH-P returned to baseline values. 
The long-term effects on urinary excretion of a coal-tar 
shampoo such as used by van Schooten and colleagues 
would be of interest.
Data that specifically link coal tar polycyclic aromatic 
hydrocarbons components such as benzo(a)pyrene to an 
increased risk for cancer in exposed populations are 
inadequate. Although lung cancer has resulted from 
polycyclic aromatic hydrocarbons exposure such as cigarette 
smoke* roofing tar* and coke-oven emissions* it cannot be 
concluded that benzo(a)pyrene is the causative agent.3 In 
particular* there are no reported studies specifically linking 
use of coal-tar-solution-containing shampoos to an increased 
risk of cancer. Current evidence suggests that the 
carcinogenic risk of coal tar* if it exists* is small. The US  
FDA* with respect to labelling* generally warns only of the 
risks that are scientifically documented* clinically significant* 
and important for the safe and effective use of products by 
average consumers,
William J Goldman
WyettvAyerst International, PO Box 8616, Philadelphia, PA 19101, USA
1 Dandruff* seborrheic dermatitis and psoriasis drug products for over- 
the-counter human use; tentative final monograph; Federal Register,
51 (146) p 27 346-60. Compilation of OTC drug regulations. 
Nonprescription Drug Manufacturers Assocation, Tab 20 p 286.
2 Hansen AM* Poulsen OM, Menne T. Longitudinal study of excretion 
of metabolites of polycyclic aromatic hydrocarbons in urine from two 
psoriatic patients, Acta Dmn Venereal 1993; 73: 188-90,
3 United States Environmental Protection Agency (EPA), Dermal 
exposure assessment: principles and applications. EPA/600/8-9I/011B. 
Interim report- Washington DC: Office of Health and Environmental 
Assessment, 1992, V
Bird attacks on milk bottles and 
Campylobacter infection
Sir—Species of campylobacter are the most commonly 
reported causes of gastrointestinal disease in the U K ,1 The 
outstanding feature of campylobacter epidemiology is the 
rise in isolations reported by laboratories over a 3-4  week 
period in the spring. In Wales die spring peak in 1994 was in 
week 21 (ending May 27)* with a 3~fold increase in reports 
over the preceding 3 weeks (figure). Previous studies in the 
UIC have identified drinking milk from bottles whose tops 
had been pecked by magpies and jackdaws as sources of 
infection.2 4 But colleagues still have difficulty in accepting 
this explanation. To find out if birds pecking milk bottle 
tops is still a significant public health problem in Wales we 
monitored human campylobacter infections from April to 
June* 1994* in collaboration with environmental health 
departments. 21 departments agreed to ask questions about 
milk bottle attacks as part of routine interviews with cases, 
Between April 1 and June 30* 657 cases were reported to 
these departments by laboratories* 551 (84%) of patients 
were interviewed and 93 (17%) reported drinking milk from 
bottles attacked by birds in the week before onset (table). In
Number April May June
Of campylobacter infections reported 112 226 319
Interviewed 87 182 282
Reporting milk bottle attacks 1 54 (30%) * 74 (26%)
Reporting drinking milk from such bottles 1 42 (23%) 50 (18%)
*0f those interviewed.
Table: Results of enhanced surveillance of campylobacter 
infection in Wales (1994)
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